We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Drug Company Seeks Review Of Cancer Treatment Patent, Joinder With Other Case

(January 18, 2018, 3:45 PM EST) -- ALEXANDRIA, Va. —West-Ward Pharmaceutical Co. on Jan. 17 took aim at a cancer treatment patent while also requesting joinder to an inter partes review (IPR) by Breckenridge Pharmaceutical Inc., in which...
To view the full article, register now.